Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients

Clinical trial NCT07254221 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07254221
Sponsor: Shiraz University of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Anthracycline-induced Cardiac Toxicity Breast Cancer Anthracycline Related Cardiotoxicity in Breast Cancer Anthracycline-induced Cardiotoxicity

Start date: 2026-02-01
Primary completion: 2028-04-21
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.